Cancer Research Meeting Calendar  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C.-N.
Right arrow Articles by Chang, K.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.-N.
Right arrow Articles by Chang, K.-J.
[Cancer Research 60, 2892-2897, June 1, 2000]
© 2000 American Association for Cancer Research


Clinical Investigations

Color Doppler Vascularity Index Can Predict Distant Metastasis and Survival in Colon Cancer Patients1

Chiung-Nien Chen, Yung-Ming Cheng, Jin-Tung Liang, Po-Huang Lee, Fon-Jou Hsieh, Ray-Hwang Yuan, Shih-Ming Wang, Mei-Fang Chang and King-Jen Chang2

Departments of Surgery [C-N. C., J-T. L., P-H. L., R-H. Y., S-M. W., K-J. C.], Pathology [Y-M. C.], and Medical Ultrasound [F-J. H., M-F. C.], National Taiwan University Hospital, Taipei 100, Taiwan, Republic of China

The purpose of this study was to investigate the clinical usefulness of the color Doppler vascularity index (CDVI) in patients with colon cancer before surgery. Forty-four patients with sonographically visible tumor mass of colon cancer were investigated. The CDVI of each tumor was determined using transabdominal color Doppler ultrasound. The CDVI was defined as the ratio of the number of the colored pixels within a tumor section to the number of total pixels in that specific tumor section and was calculated by using Encomate software (Electronic Business Machine Co. Ltd., Taipei, Taiwan). The correlation between the CDVI and clinicopathological factors, mode of recurrence, and patient survival was studied. For comparison, microvessel density (the mean number of microvessels in three areas of highest vascular density at x200 magnification) of the tumors of these 44 patients was also evaluated by using immunohistochemical staining of surgical specimens with anti-CD34. The microvessel density was not correlated with Dukes’ classification, clinicopathological factors, and survival. The CDVI was significantly higher in the patients with lymph node metastases and vascular invasion than in those without such metastases and invasion (P = 0.006 and P = 0.0098, respectively). Moreover, in patients with a high CDVI (>15%) and positive vascular invasion, survival was significantly poorer than in those with low CDVI (<=15%) and negative invasion (P = 0.0037 and 0.0039, respectively). Multivariate analysis indicated that liver metastasis, vascular invasion, and CDVI are independent prognostic factors in the patients with colon cancer. According to the mode of recurrence in 36 patients who underwent curative resection, the frequency of the distant organ recurrence was significantly higher in the high CDVI group (40%) than in the low CDVI group (0%). The CDVI is a good preoperative indicator of recurrence and patient survival in colon cancer. Thus, the CDVI may be helpful in stratifying patients for adjuvant therapy.




This article has been cited by other articles:


Home page
RadiologyHome page
C. Hsu, C.-N. Chen, L.-T. Chen, C.-Y. Wu, F.-J. Hsieh, and A.-L. Cheng
Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler US and Analysis of Circulating Angiogenic Factors
Radiology, May 1, 2005; 235(2): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Agarwal, S. Strickland, I. A. McNeish, D. C. Patel, M. Foskett, J. E. Boultbee, E. S. Newlands, and M. J. Seckl
Doppler Ultrasonography of the Uterine Artery and the Response to Chemotherapy in Patients with Gestational Trophoblastic Tumors
Clin. Cancer Res., May 1, 2002; 8(5): 1142 - 1147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.